TELO stock

Telomir Pharmaceuticals, Inc. Common Stock (TELO) financials · $86.0M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Telomir Pharmaceuticals, Inc. Common Stock (TELO) $86.0M cap.

Cached annual income statement
LineFY2025FY2024
Net Income-$10.4M-$16.5M
EPS (Diluted)-$0.33$0.56
Cached annual balance sheet
LineFY2025FY2024
Total Assets$7.34M$1.32M
Current Assets$7.34M$1.32M
Cash & Equivalents$7.29M$1.27M
Total Liabilities$1.43M$681.0K
Current Liabilities$1.43M$681.0K
Shareholders' Equity$5.91M$643.0K
Retained Earnings-$41.0M-$30.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$3.69M-$5.07M
Financing Cash Flow$9.71M$6.34M
Net Change in Cash$6.02M$1.26M
These statements as JSON? API free 100/day

FAQ

What is TELO P/E and revenue?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) $86.0M cap.

What is TELO revenue?

TELO income-statement cache has no revenue figure yet.

Is TELO profitable?

Telomir Pharmaceuticals, Inc. Common Stock last cached net income is -$10.4M (FY2025).

What are TELO total assets?

Telomir Pharmaceuticals, Inc. Common Stock last cached total assets are $7.34M (FY2025).

What is TELO free cash flow?

No cached cash-flow row for TELO yet.

Not investment advice. Cached statements, not a live tape.